FRPT enters August with an unusual combination: short interest near 18% of the float, yet options positioning at its most bullish reading of the past year.
The options market is sending an unusually confident signal. The put/call ratio has dropped to 0.473 — just above the 52-week low of 0.4716 — and runs more than one standard deviation below its 20-day average of 0.59. That means call buying is dominating to a degree rarely seen in this name over the past twelve months. The contrast with a year that saw the PCR spike as high as 2.15 is stark. Something shifted in late July: the PCR ran above 0.69 as recently as July 10, then fell sharply as the stock climbed through the back half of the month.
Short interest tells a structurally cautious but less aggressive story than it once did. Bears still hold 18.2% of the free float — a genuinely high level for a consumer staples name — but the total short position has quietly unwound about 7% from its early July peak near 9.6 million shares, settling around 8.86 million. Borrow is nearly free at 0.45% annualised, and availability is ample at 279%, meaning lenders hold nearly three shares available for every one currently borrowed. There is no squeeze pressure in the market right now; bears can add or exit freely. The ORTEX short score of 64.3 is elevated but has edged lower over the past week, consistent with the modest short covering that has accompanied the stock's 11% gain over the past month.
The Street is constructively positioned, though not without reservations. JP Morgan was the most recent mover, lifting its target to $72 from $68 while maintaining an Overweight rating in late July — a meaningful data point given it upgraded from Neutral in May. That puts the bellwether name firmly in the bull camp. Wells Fargo and BofA Securities both trimmed targets in early July, though neither changed their ratings. The consensus mean target of $81.50 implies roughly 30% upside from the current $62.38 price, a gap that reflects ongoing growth premium expectations. Bulls point to Costco distribution gains, improving margins from operational efficiency, and sustained household penetration growth. Bears counter that FRPT generates almost all revenue from one geography, and that recent volume growth owes more to shelf space expansion than to organic demand acceleration — a distinction that matters when shelf space gains plateau. On valuation, the trailing P/E has risen to 34.2 over the past month, up nearly two points in 30 days, and the EV/EBITDA of 13.1 has compressed slightly — a sign the earnings line is catching up to the stock price. The EPS surprise factor score ranks in the 99th percentile, meaning the company has beaten estimates with exceptional consistency; the forward growth score, at just 9th percentile, captures the Street's muted expectations for the year ahead.
Institutional flows add a layer of interest. AllianceBernstein added 1.53 million shares in the most recent reported quarter — nearly a full position build — and Capital Research added 1.4 million. Wellington and Wasatch also increased. BlackRock, the largest holder at nearly 12% of shares, added modestly. The size of the AB and Capital Research additions is notable given the stock was trading in the $47–$55 range through that period; those buyers are already sitting on gains. Insider activity runs the other way: CEO William Cyr sold approximately $2.5 million of stock in late May at prices around $47–$51. The sales carry low significance scores and likely reflect planned disposals rather than a conviction call, but they do bracket the institutional buying window.
The next earnings date is pencilled in for November 2. The most recent print, filed August 3, drove a 4.8% single-day gain — the stock has now added another 4.6% on August 4. The post-results setup is the key watch: with options leaning heavily bullish, short interest still elevated, and institutional holders having built positions below current prices, how the company characterises FY26 guidance and distribution channel momentum will determine whether this unusual convergence resolves higher or snaps back toward the bears.
See the live data behind this article on ORTEX.
Open FRPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
